These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19624982)

  • 21. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.
    Miranda-Verástegui C; Llanos-Cuentas A; Arévalo I; Ward BJ; Matlashewski G
    Clin Infect Dis; 2005 May; 40(10):1395-403. PubMed ID: 15844060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imiquimod: liver damage: topical use, systemic effects.
    Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19746527
    [No Abstract]   [Full Text] [Related]  

  • 23. Imiquimod 5% cream for the treatment of actinic keratoses.
    Somani N; Rivers JK
    Skin Therapy Lett; 2005 Mar; 10(2):1-6. PubMed ID: 15986078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
    Urosevic M; Dummer R; Conrad C; Beyeler M; Laine E; Burg G; Gilliet M
    J Natl Cancer Inst; 2005 Aug; 97(15):1143-53. PubMed ID: 16077073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids.
    Berman B; Kaufman J
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S209-11. PubMed ID: 12271279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune response modification: imiquimod.
    Tyring S
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S11-3. PubMed ID: 9842095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psoriasis induced by topical imiquimod.
    Wu JK; Siller G; Strutton G
    Australas J Dermatol; 2004 Feb; 45(1):47-50. PubMed ID: 14961909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients.
    Buettiker UV; Yawalkar NY; Braathen LR; Hunger RE
    Arch Dermatol; 2008 Jul; 144(7):943-5. PubMed ID: 18645150
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study.
    Rosen T; Harting M; Gibson M
    Dermatol Surg; 2007 Apr; 33(4):427-31; discussion 431-2. PubMed ID: 17430376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Imiquimod--clinical efficacy].
    Beutner KR
    Ann Dermatol Venereol; 2000; 127(10 Suppl):3S19-3S21. PubMed ID: 11116859
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of topical 5% imiquimod during pregnancy: a case series.
    Einarson A; Costei A; Kalra S; Rouleau M; Koren G
    Reprod Toxicol; 2006 Jan; 21(1):1-2. PubMed ID: 16039826
    [No Abstract]   [Full Text] [Related]  

  • 32. Imiquimod as an immune response modulator in infectious conditions.
    Skinner RB
    Postgrad Med; 2002 Dec; 112(6 Suppl Using):8-16. PubMed ID: 19667608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lip silicone granulomatous foreign body reaction treated with aldara (imiquimod 5%).
    Baumann LS; Halem ML
    Dermatol Surg; 2003 Apr; 29(4):429-32. PubMed ID: 12656829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New perspective in immunotherapy: local imiquimod treatment].
    Kemény L; Nagy N
    Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imiquimod therapy for molluscum contagiosum.
    Liota E; Smith KJ; Buckley R; Menon P; Skelton H
    J Cutan Med Surg; 2000 Apr; 4(2):76-82. PubMed ID: 11179929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imiqimod in clinical practice.
    Trofatter KF
    Eur J Dermatol; 1998; 8(7 Suppl):17-9; discussion 20-2. PubMed ID: 10387959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current and potential uses of imiquimod.
    Chang YC; Madkan V; Cook-Norris R; Sra K; Tyring S
    South Med J; 2005 Sep; 98(9):914-20. PubMed ID: 16217984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women.
    Garland SM; Waddell R; Mindel A; Denham IM; McCloskey JC
    Int J STD AIDS; 2006 Jul; 17(7):448-52. PubMed ID: 16820073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical imiquimod.
    Pearson GW; Langley RG
    J Dermatolog Treat; 2001 Mar; 12(1):37-40. PubMed ID: 12171687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments.
    Gracia-Cazaña T; González S; Gilaberte Y
    Actas Dermosifiliogr; 2016 Nov; 107(9):730-739. PubMed ID: 27436800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.